This study demonstrated the inhibitory effects of artesunate on ovarian cancer and reconfirmed the function of Th1 cells and IFN-γ in fighting against cancer, offering an essential reference and perspective for immunotherapy development. The gene discussed is IFNG; the disease is ovarian carcinoma.